SCHEMBL22070026

SCHEMBL22070026

c1ccc(-c2nc(-c3cccc(-c4ccc5c(ccc6c7ccccc7oc56)c4)c3)nc(-c3ccc4oc5ccccc5c4c3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.42
▸ PLA2G4A P47712 3/20 0.42
▸ PLA2G10 O15496 1/20 0.42
▸ ALDH1A1 P00352 5/20 0.40
▸ HPGD P15428 4/20 0.40
▸ ALOX5 P09917 1/20 0.39
▸ MAPT P10636 7/20 0.38
▸ PTPRF P10586 2/20 0.38
▸ PTPN2 P17706 2/20 0.38
▸ PTPN1 P18031 2/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ SENP7 Q9BQF6 1/20 0.38
▸ SENP6 Q9GZR1 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.37
▸ TSHR P16473 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ CHEK2 O96017 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22879988 0.96 ALOX5 (0.41) PLA2G2APLA2G4APLA2G10ALDH1A1HPGD
SCHEMBL22071478 0.95 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALDH1A1HPGD
SCHEMBL23134249 0.95 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALDH1A1HPGD
SCHEMBL23134132 0.95 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALDH1A1HPGD
SCHEMBL22070027 0.95 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALDH1A1HPGD
SCHEMBL24634398 0.95 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALDH1A1HPGD
SCHEMBL22070031 0.95 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALDH1A1HPGD
SCHEMBL22483255 0.95 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALDH1A1HPGD
SCHEMBL22069966 0.94 HCRTR1 (0.41) PLA2G2APLA2G4APLA2G10ALDH1A1HPGD
SCHEMBL23134250 0.94 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3664172-B1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-09-06 — — EP disclosed
US-20210091314-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-03-25 — — US disclosed
EP-3664172-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE Samsung SDI Co., Ltd. (KR) 2020-06-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210091314-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 PLA2G2A 4237/4885PLA2G4A 4081/4885PLA2G10 4149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback